Le Lézard
Classified in: Health, Science and technology
Subject: PDT

InventHelp Inventor Develops Mobile App for Prescription Medication Data (OSK-534)


PITTSBURGH, May 30, 2024 /PRNewswire/ -- "I'm a pharmacist, and I thought there could be a convenient app for scanning, storing and updating a patient's prescriptions and other medical information," said an inventor, from Baton Rouge, La., "so I invented the Q R X. My design ensures that patients and health care professionals always have access to complete and updated medication and personal medical information records when needed."

The invention provides a mobile software application and online cloud service to provide patients, doctors and pharmacists with accurate and current medication prescription data and patient medical profiles. In doing so, it allows for convenient and accurate prescription refills. It also reduces the potential for medication errors. The invention features an innovative design that is easy to use so it is ideal for patients, doctors and pharmacists.

The original design was submitted to the New Orleans sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-OSK-534, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 21:09
Exhibition on Design Intelligence by China Academy of Art held in China
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Announces Private Placement Financing
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
CGTN America & CCTV UN: 'The Classic Quotes by Xi Jinping' airs in Kazakhstan
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
SD Networks Set Framework for Asia Pacific Modernization
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

More news about Science and technology...


News published on and distributed by: